Pipeline

TSBIO Life Sciences will do it's best.

파이프라인 일정
Pipeline Stategic frame work Start lead identification Start lead Optimisation Start Non-Clinical development IND submission Start
Phase I
Start
Phase II
Start
Phase III
BLA submission Launch
자연살해 세포치료제 TS-NK01-BR
자가유래 NK세포치료제 /유방암

2022 4Q

TS-NK02
동종유래 NK세포치료제

2023.2Q

중간엽줄기 세포치료제 TS-SC01-RC
자가유래 중간엽줄기세포치료제 /회전근개

2023.2Q

TS-SC01
동종유래 중간엽줄기세포치료제

2023.3Q